Zheng Wang

机构：Ministry of Education of the People's Republic of China, Army Medical University, Sun Yat-sen University, Tianjin University, Dalian Medical University, Nankai University, Fudan University, People 's Hospital of Jilin Province, Ministry of Education, Second Affiliated Hospital of Chongqing Medical University, Shanghai Institute of Organic Chemistry, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Henan Provincial People's Hospital, Ministry of Education, Tianjin Chest Hospital, Chongqing Medical University · ORCID：0000-0003-4838-0965

发表论文 59 篇 · 总被引 2127 次 · h-index 21

代表论文

• Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition) (2022 · HepatoBiliary Surgery and Nutrition · 被引 203)
• Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomics (2021 · Hepatology · 被引 110)
• Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection (2022 · Molecular Cancer · 被引 90)
• Silk Sericin‐based ROS‐Responsive Oxygen Generating Microneedle Platform Promotes Angiogenesis and Decreases Inflammation for Scarless Diabetic Wound Healing (2024 · Advanced Functional Materials · 被引 75)
• Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria (2025 · Journal for ImmunoTherapy of Cancer · 被引 21)
• Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis (2021 · Frontiers in Oncology · 被引 21)